IDENTIFICATION AND ANALYSIS OF ADVERSE DRUG REACTIONS ASSOCIATED WITH CANCER CHEMOTHERAPY IN HOSPITALIZED PATIENTS
Keywords:
Adverse drug reactions, cancer, chemotherapyAbstract
Objective: To analyze the incidence of adverse drug reactions (ADRs) associated with chemotherapeutic drugs and study its management.
Methods: A prospective observational study was carried out on hospitalized patients undergoing cancer chemotherapy. The identified ADRs were assessed for causality, severity and preventability.
Results: Among 120 patients followed 100 patients developed 161 ADRs. Most common ADRs were anemia, leucopenia, mucositis fever, and chills. As per the WHO causality assessment 87(54.0%) ADRs were probable whereas with the Naranjo's scale 98(60.9%) were probable. Moderate reactions were 59.62%. Majority 122 (75.8%) of the ADRs were not preventable. Most of ADRs were implicated with cisplatin followed by 5-Fluro-uracil and the combination drugs which included FAC (Flurouracil, adriyamycin, cyclophosphamide) regimen, Paclitaxel, and Carboplatin (PC) regimen.
Conclusion: Patients undergoing cancer chemotherapy have higher chances to develop ADRs. Those patients on chemotherapy with cisplatin followed by 5-Fu and combination drugs which include FAC and PC regimen should be strictly monitored for the early detection and prompt management of the ADR to prevent morbidity and mortality.
Keywords: Adverse drug reactions, Cancer, Chemotherapy, Predictable, Management.Downloads
References
Parthasarathi G, Hansen KN, Nahata MC. A textbook of clinical pharmacy practice. 2nd ed. University press: (India); 2015.
Kirthi C, Afsal A, Reddy M, Ali AS, Aparna Y, Sharma S. A study on the adverse drug effects of anti-cancer drugs in an oncology center of a tertiary care hospital. Int J Pharm Sci 2014;6:580-3.
Goyal YN, Solanki KC, Mistry RA, Joshi ND, Singh AP, Gajera MV. The pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in Gujarat. Int J Sci Res 2014;3:77-9.
ASHP Guidelines on adverse drug reaction monitoring and reporting. Medication Misadventures-guidelines; 1995. p. 219-21.
Khandelwal S, Bairy KL, Vidyasagar MS, Chogtu b, Sharan K. Adverse drug reaction profile of cancer patients on chemotherapy in a tertiary care hospital. Int J Pharm Biol Sci 2015;6:233-44.
Prasad A, Datta PP, Bhattacharya J, Pattanayak C, Ashok, Chauhan AS, et al. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in eastern India. J Pharmacovigilance 2013;1:1-4.
Poddar S, Sultana R, Sultana R, Akbor MM, Azad MAK, Hasnat A. Pattern of adverse drug reactions due to cancer chemotherapy in a tertiary care teaching hospital in bangladesh, dhaka univ. J Pharm Sci 2009;8:11-6.
The use of the WHO-UMC system for standardized case causality assessment http://who-umc.org/Graphics/ 24734. Pdf. [Last accessed on 05 Feb 2016].
Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm 1992;49:229-32.
Schumock TG, Thorton PJ. Focusing on the preventability of adverse drug reactions. Hospital Pharm 1992;27:538.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.
Shargel L, Mutnick AH, Souney PF, Swanson LN. Comprehensive pharmacy practice review. Eight edition. Wolters Kluwer (India) Pvt; 2013. p. 1001-18.
Hettihewa LM, Sirisena B. Causality assessment and the severity of the adverse drug reactions actively detected in hospital in-patients in tertiary care hospital, srilanka. Asian J Res Biol Pharm Sci 2014;2:1-10.
Thapaliya K, A Shreestha, S Prajapati, R Subedi, S Giri. Study of a pattern of adverse drug reaction due to cancer chemotherapy and their management in hospitalized patient in B P Koirala memorial cancer hospital. J Computer Med Communication 2014;4:24-8.
Tanzania food drugs and cosmetics act. Guidelines for monitoring and reporting adverse drug reactions TFDA; 2006.
American cancer society. Cancer facts and fig. Atlanta: american cancer society; 2015.